Long remember $ARWR CEO indicating ARO-HBV is an immunomodulator. $VIR proposed  use of IFN seems like a red🚩.  Who would want a future HBV drug regimen using pegIFNa? An effective RNAi drug likely produces sufficient amounts of naturally occuring IFNs. $JNJ + $ARWR